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T reatments for preterm infants has improved,  and key parameters such as survival rates and 
neurodevelopmental outcomes have been evaluated 
[1-6].  In 2003,  a database of very low birth weight 
infants (VLBWIs) was established in Japan (the 
Neonatal Research Network of Japan [NRNJ]) and the 
results of several analyses of the database have been 
reported [6,7].  Since opening in 2005,  our hospital 
has provided care for nearly half of all VLBWIs born 
in Kochi prefecture,  Japan.  As such,  we feel that 
creating our own prefecture-wide VLBWIs database 
and comparing our analysis results with those of other 
studies would be useful.
　 In the present study,  we attempted to clarify sur-
vival and neurodevelopmental outcomes and identify 
risk factors for death or neurodevelopmental impair-
ment (NDI) in VLBWIs.
Materials and Methods
　 Data for our retrospective analyses were obtained 
from the medical records of all surviving infants who 
were born weighing 1,500 g at the Kochi Health 
Sciences Center in Kochi,  Japan between March 2005 
and March 2012.  The cases of infants were excluded 
if the infants had any chromosomal abnormalities,  
multiple anomalies,  congenital infection or disease 
with a poor prognosis.
　 Confounding factors. We adjusted the data 
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We sought to clarify the survival and neurodevelopmental outcomes of very low birth weight infants 
(VLBWIs) and to identify risk factors for death or neurodevelopmental impairment (NDI) in VLBWIs 
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for the following confounding factors: maternal age,  
primiparity,  maternal diabetes,  pregnancy-induced 
hypertension,  clinical chorioamnionitis,  premature 
rupture of membrane (PROM),  antenatal corticoste-
roid use,  cesarean section,  sex,  gestational age (GA),  
birth weight (BW),  Apgar score (AS) at 1 and 5 min,  
respiratory distress syndrome (RDS),  chronic lung 
disease (CLD),  patent ductus arteriosus (PDA),  nec-
rotizing enterocolitis (NEC),  sepsis,  intraventricular 
hemorrhage (IVH),  retinopathy of prematurity (ROP),  
and periventricular leukomalacia (PVL) [8-11].  
Clinical chorioamnionitis was diagnosed based on clin-
ical ﬁndings such as maternal fever,  leukocytosis,  or 
local pain during pregnancy,  labor or delivery [12].  
Antenatal corticosteroid use was deﬁned as the admin-
istration of at least one dose of corticosteroid to the 
mother at any time before delivery to accelerate fetal 
lung maturity.  The GA was determined by the best 
estimate based on an early prenatal ultrasound exam-
ination,  the last menstrual period,  and the physical 
examination of the infant at birth.  Small for gesta-
tional age (SGA) was deﬁned as a BW less than the 
10th percentile of the standard BW for GA as pub-
lished by the Japan Pediatric Society [13].  RDS was 
deﬁned as that diagnosed by clinical and radiographic 
ﬁndings.  CLD was deﬁned as requiring oxygen at 36 
weeks (corrected age).  PDA was deﬁned as receiving 
indomethacin treatment.  NEC was deﬁned by a Bell 
classiﬁcation of stage II or greater [14].  Sepsis was 
diagnosed by blood culture.  The grade of IVH was 
diagnosed by cranial echography according to the clas-
siﬁcation of Papile,  with grades III and IV corre-
sponding to severe IVH [15].  ROP was deﬁned as 
being treated with laser coagulation.
　 Outcomes. Outcomes included death before or 
after discharge,  transfer before or after discharge,  
NDI,  no NDI and lost to follow-up (LTF).  Death or 
transfer after discharge and NDI were evaluated 3 
years (i.e.,  36-42 months).  NDI was deﬁned as any of 
the following: cerebral palsy,  unilateral or bilateral 
blindness,  severe hearing impairment,  or develop-
mental delay.  Developmental delay was deﬁned as a 
developmental quotient (DQ) ＜70 on the Kyoto Scale 
of Psychological Development (KSPD) test,  or as 
determined by the physicians of infants who did not 
undergo this test [4,16].
　 Statistical analysis. After the exclusions were 
made,  we divided our study population was divided 
into groups according to BW (every 250 g) and GA 
(every 2 weeks).  We then compared the rates of death 
or NDI and other parameters between the present 
study and that by Kono et al.,  which was based on 
NRNJ [4].
　 We divided the evaluated cases into 2 groups based 
on their clinical characteristics of evaluated cases 
were divided into 2 groups (no NDI vs. death after 
discharge or NDI).  We compared the groups by per-
forming a univariate logistic regression analysis,  and 
we used a simple descriptive analysis to calculate 
mean diﬀerences,  risk ratios,  and 95  conﬁdence 
intervals (95 CIs).  For death after discharge or 
NDI,  a multivariate logistic regression analyses was 
performed to adjust for confounding factors including 
primiparity,  pregnancy-induced hypertension,  clinical 
chorioamnionitis,  antenatal corticosteroid use,  male 
sex,  GA,  AS at 5 min ＜7,  RDS,  CLD,  PDA,  NEC,  
sepsis,  severe IVH,  ROP and PVL,  all of which have 
been found to aﬀect neurodevelopmental outcomes in 
VLBWIs [5,9,17].  GA but not BW was included in 
the models because the two measurements are colinear 
[5].  We also calculated the adjusted odds ratios 
(AORs) and their 95 CIs were also calculated.
　 Among the infants with KSPD,  we analyzed the 
DQ scores from the KSPD test for risk factors by 
using the least-squares method.  Lastly,  we compared 
the results of our evaluations of the cases involving 
LTF and transfer after discharge.
　 All statistical analyses were performed using JMP 
10.0.2 software (SAS Institute,  Cary,  NC,  USA),  
with p-values ＜0.05 indicating statistical signiﬁcance.  
The present study protocol was approved by the 
Ethics Review Committee of the Kochi Health 
Sciences Center.
Results
　 The data from 217 of the 225 infants born during 
the speciﬁed period were used for our analysis 
(Fig.  1); the eight remaining cases were excluded for 
reasons including lung sequestration,  cerebral arterio-
venous malformation,  right lung agenesis with esoph-
ageal atresia,  double outlet right ventricle with 
hydrocephalus,  holoprosencephaly,  congenital cyto-
megalovirus infection,  congenital muscular dystrophy,  
and trisomy 13.
　 The evaluated cases included infants with no NDI 
346 Maruyama et al. Acta Med.  Okayama　Vol.  70,  No.  5
(n＝117),  NDI (n＝38; 1 infant with cerebral palsy,  
2 with visual impairment,  and 35 with developmental 
delays: 18 with DQ ＜70 and 17 as determined by 
physicians),  and those who died (n＝2).  Infants,  who 
were diagnosed with developmental delays,  were clin-
ically judged and unable to take the test.  Of the 155 
surviving infants (with or without NDI),  92 had 
undergone the KSPD test.
　 Neonatal outcomes by BW group are shown in 
Fig.  2 and Table 1.  The numbers( ) of each group 
were 2 (0.9) for infants weighing 500 g,  39 (18.0) 
for those weighing 501-750 g,  47 (21.7) for 751-
1,000 g,  67 (30.9) for 1,001-1,250 g,  and 62 (28.6) 
for 1,251-1,500 g.  The comparison of our present 
ﬁndings to those of Kono et al.  [4] revealed the fol-
lowing: the rates of death before discharge in the two 
studies were 6.9  versus 7.6  (p＝0.722): the rate of 
death after discharge was 0.9  versus 0.7  (p＝
0.642: ,  the rate of death plus NDI was 25.3  ver-
sus 19.6  (p＝0.039): and the rate of no NDI was 
53.9  versus 47.6  (p＝0.125),  respectively.  The 
rate of death or NDI in each BW group is shown in 
Table 2.  The death/NDI rate for the 751-1,000 g 
BW group and that of the total population in the pres-
ent study were signiﬁcantly higher than the corre-
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Table 1　 Outcomes by birth weight group (every 250 g)
Outcome 500 g(n＝2)
501-750 g
(n＝39)
751-1,000 g
(n＝47)
1,001-1,250 g
(n＝67)
1,251-1,500 g
(n＝62)
Total
(n＝217)
Death BD n (%) 0 (0) 6 (15.4) 3 (6.4) 5 (7.5) 1 (1.6) 15 (6.9)
Death AD n (%) 0 (0) 2 (5.1) 0 (0) 0 (0) 0 (0) 2 (0.9)
NDI n (%) 2 (100) 9 (23.1) 17 (36.2) 5 (7.5) 5 (8.1) 38 (17.5)
No NDI n (%) 0 (0) 18 (46.2) 21 (44.7) 37 (55.2) 41 (66.1) 117 (53.9)
Transfer BD n (%) 0 (0) 2 (5.1) 0 (0) 1 (2.1) 1 (1.6) 4 (1.8)
Transfer AD n (%) 0 (0) 2 (5.1) 2 (4.3) 8 (11.9) 3 (4.8) 15 (6.9)
LTF n (%) 0 (0) 0 (0) 4 (8.5) 11 (16.4) 11 (17.7) 26 (12.0)
AD,  after discharge; BD,  before discharge; LTF,  lost to follow-up; NDI,  neurodevelopmental impairment.
 2005-2012 KHSC, BW ≤1,500ｇ(n＝225)
Discharged infants (n＝198)
Death before discharge (n＝15)
Exclusion (n＝8)
Transfer before discharge (n＝4)
No NDI (n＝117)
Lost to follow-up (n＝26)
Evaluated cases at 3 years old (n=157)
Transfer after discharge (n＝15)
Study population (n＝217)
Death after discharge (n＝2)
NDI (n＝38)
Fig. 1　 Flow chart of the recruitment of very low birth weight 
infants born at the Kochi Health Sciences Center in Kochi, Japan 
between March 2005 and March 2012.
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Fig. 2　 Neonatal outcomes of the study infants (n＝217) by birth 
weight (every 250 g).  Black,  death before discharge; gray,  death 
after discharge; vertical stripes,  transfer before discharge; diago-
nal lines,  NDI; white,  no NDI; wave,  transfer after dis-
charge; dotted,  lost to follow-up.
sponding rates observed by Kono et al.
　 Neonatal outcomes according to GA group are 
shown in Fig.  3 and Table 3.  The rates of death or 
NDI in each GA group were 50.0 ,  59.3 ,  42.9 ,  
24.0 ,  3.4 ,  13.3 ,  0 ,  0 ,  and 100  at 22-23,  
24-25,  26-27,  28-29,  30-31,  32-33,  34-35,  36-37,  
and 38-39 gestational weeks,  respectively.
　 The characteristics of the infants who died or were 
transferred before discharge are shown in Table 4.  
The main causes of death were IVH (n＝6),  sepsis 
(n＝4),  and persistent pulmonary hypertension of the 
newborn (n＝3).
　 The univariate logistic regression analysis for the 
evaluated cases (no NDI vs. death after discharge or 
NDI) (Table 5) revealed that the characteristics of the 
infants who died after discharge or had NDI were 
early GA,  low BW,  low AS at 1 min,  RDS,  CLD,  
PDA,  ROP,  and PVL.
　 We performed a multivariate logistic regression 
analysis to assess death after discharge or NDI in the 
evaluated cases.  As shown in Table 6,  the signiﬁcant 
risk factors included early GA (weeks) (AOR [95
CI,  p-value],  0.72 [0.54-0.94,  0.017]) and PVL 
(6.90 [1.35-38.25,  0.021]).
　 Our analysis of the DQ scores on the KSPD test 
(n＝92) revealed that the signiﬁcant risk factors for 
low DQ were early GA,  severe IVH,  ROP and PVL 
(p＝0.017,  0.021,  0.019 and 0.014,  respectively) 
(Table 7).
　 Lastly,  we compared the evaluated cases versus 
those that were either transferred after discharge or 
LTF (Table 8).  The characteristics of the LTF and 
transfer after discharge cases were late GA,  high 
BW,  high AS at 1 min,  and less ROP.
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Table 2　 Rates of death or NDI by birth weight group for the present study versus that by Kono et al. [4].
(%) 500 g 501-750 g 751-1,000 g＊ 1,001-1,250 g 1,251-1,500 g Total＊
Present study (%) 100 43.6 42.6 14.9 9.7 25.3
Kono et al. (%) 65.6 40.1 20.8 9.8 8.5 19.6
p-value 0.308 0.668 0.0005 0.184 0.739 0.039
NDI,  neurodevelopmental impairment.  ＊p＜0.05 for the diﬀerence between the two studiesʼ data.
Table 3　 Outcomes by gestational age groups (every 2 weeks)
Outcome 22-23w(n＝2)
24-25w
(n＝27)
26-27w
(n＝49)
28-29w
(n＝50)
30-31w
(n＝58)
32-33w
(n＝15)
34-35w
(n＝11)
36-37w
(n＝4)
38-39w
(n＝1)
Total
(n＝217)
Death BD n (%) 1 (50.0) 6 (22.2) 3 (6.1) 3 (6.0) 0 (0) 1 (6.7) 0 (0) 0 (0) 1 (100) 15 (6.9)
Death AD n (%) 0 (0) 0 (0) 1 (2.0) 1 (2.0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 2 (0.9)
NDI n (%) 0 (0) 10 (37.0) 17 (34.7) 8 (16.0) 2 (3.4) 1 (6.7) 0 (0) 0 (0) 0 (0) 38 (17.5)
No NDI n (%) 0 (0) 10 (37.0) 19 (38.8) 25 (50.0) 43 (74.1) 11 (73.3) 8 (72.7) 1 (25.0) 0 (0) 117 (53.9)
Transfer BD n (%) 1 (50.0) 1 (3.7) 1 (2.0) 0 (0) 0 (0) 0 (0) 1 (9.0) 0 (0) 0 (0) 4 (1.8)
Transfer AD n (%) 0 (0) 0 (0) 3 (6.1) 6 (12.0) 3 (5.2) 1 (6.7) 1 (9.0) 1 (25.0) 0 (0) 15 (6.9)
LTF n (%) 0 (0) 0 (0) 5 (10.2) 7 (14.0) 10 (17.2) 1 (6.7) 1 (9.0) 2 (50.0) 0 (0) 26 (12.0)
AD,  after discharge; BD,  before discharge; LTF,  lost to follow-up; NDI,  neurodevelopmental impairment.
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Fig. 3　 Neonatal outcomes of thestudy infants (n＝217) by ges-
tational week (every 2 weeks).  Black,  death before dis-
charge; gray,  death after discharge; vertical stripes,  transfer 
before discharge; diagonal lines,  NDI; white,  no NDI; wave,  
transfer after discharge; dotted,  lost to follow-up.
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Table 4　 Characteristics of infants who either died (n＝15) or were transferred before discharge (n＝4)
No. Death/Transfer GA (weeks) BW (g) Length of NICU stay Cause
1 D 23 506 0 Asphyxia
2 D 24 661 371 CAM,  CLD
3 D 24 676 4 IVH 4
4 D 24 808 1 CAM,  PPHN
5 D 25 558 9 IVH 3,  Sepsis
6 D 25 592 6 PPHN,  IVH 4
7 D 25 652 27 Sepsis
8 D 26 880 8 IVH 4
9 D 26 1,032 9 TTTS,  PA,  IVH 4
10 D 27 852 3 IVH 4
11 D 28 1,186 0 Hydrops
12 D 29 1,070 52 Ileus,  Sepsis
13 D 29 1,152 27 Sepsis
14 D 33 1,404 30 Congenital intestinal obstruction
15 D 38 1,184 50 PPHN
16 T 23 610 116 ROP
17 T 25 696 106 ROP
18 T 27 1,090 25 PDA
19 T 34 1,440 71 PA
BW,  birth weight; CAM,  chorioamnionitis; CLD,  chronic lung disease; GA,  gestational age; IVH,  intraventricular hemorrhage; PA,  pul-
monary atresia; PDA,  patent ductus arteriosus; PPHN,  persistent pulmonary hypertension of the newborn; ROP,  retinopathy of prematu-
rity; TTTS,  twin-to-twin transfusion syndrome.
Table 5　 Characteristics of evaluated cases (n＝157)
Characteristic No NDI (n＝117) Death AD or NDI (n＝40) MD or RR (95%CI) P-value
Maternal age (years) Mean (SD) 32.1 (5.3) 30.6 (6.3) 1.5 (－0.5-3.5) 0.145
Primiparity n (%) 61 (52.1) 23 (57.5) 0.91 (0.66-1.2) 0.557
Diabetes n (%) 5 (4.3) 0 (0) － 0.330
PIH n (%) 32 (27.4) 9 (22.5) 1.2 (0.64-2.3) 0.547
Chorioamnionitis n (%) 14 (12.0) 4 (10.0) 1.2 (0.42-3.4) 1.000
PROM n (%) 41 (35.0) 11 (27.5) 1.3 (0.73-2.2) 0.382
ACS n (%) 68 (58.1) 28 (70.0) 0.83 (0.64-1.1) 0.183
Cesarean section n (%) 106 (90.6) 36 (90.0) 1.01 (0.89-1.1) 1.000
Male n (%) 62 (53.0) 18 (45.0) 1.2 (0.80-1.7) 0.383
Gestational age (weeks)＊ Mean (SD) 29.8 (2.7) 27.4 (2.0) 2.4 (1.5-3.3) ＜.0001
Birth weight (g)＊ Mean (SD) 1,096 (264) 886 (266) 210 (115-306) ＜.0001
SGA n (%) 52 (44.4) 11 (27.5) 1.6 (0.94-2.8) 0.059
AS at 1 min ＜7＊ n (%) 62 (53.0) 30 (75.0) 0.71 (0.55-0.90) 0.015
AS at 5 min ＜7 n (%) 28 (23.9) 15 (38.5) 0.62 (0.37-1.0) 0.079
RDS＊ n (%) 82 (70.1) 38 (95.0) 0.74 (0.64-0.85) 0.0009
CLD＊ n (%) 5 (4.3) 6 (15.0) 0.28 (0.092-0.88) 0.022
PDA＊ n (%) 38 (32.5) 23 (57.5) 0.56 (0.39-0.82) 0.005
NEC n (%) 1 (0.9) 0 (0) － 1.000
Sepsis n (%) 1 (0.9) 3 (7.5) 0.11 (0.012-1.1) 0.051
Severe IVH n (%) 1 (0.9) 2 (5.0) 0.17 (0.016-1.8) 0.160
ROP＊ n (%) 18 (15.4) 18 (45.0) 0.34 (0.20-0.59) 0.0001
PVL＊ n (%) 4 (3.4) 7 (17.5) 0.20 (0.060-0.63) 0.006
ACS,  antenatal corticosteroid use; AD,  after discharge; AS,  Apgar score; CI,  conﬁdence interval; CLD,  chronic lung disease; IVH,  
intraventricular hemorrhage; MD,  mean diﬀerence; NEC,  necrotizing enterocolitis; NDI,  neurodevelopmental impairment; PDA,  patent 
ductus arteriosus; PIH,  pregnancy-induced hypertension; ROP,  retinopathy of prematurity; PROM,  premature rupture of the membranes;  
PVL,  periventricular leukomalacia; RDS,  respiratory distress syndrome; RR,  risk ratio; SGA,  small for gestational age.  ＊indicates 
p-value＜0.05.
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Table 6　 Multivariate logistic regression analysis for death after 
discharge or NDI
Risk factors AOR 95%CI P-value
Primiparity 1.57 0.64-3.98 0.321
PIH 2.01 0.62-6.56 0.243
Chorioamnionitis 0.58 0.13-2.14 0.422
ACS 1.16 0.42-3.35 0.778
Male 0.88 0.36-2.17 0.775
Gestational age (weeks)＊ 0.72 0.54-0.94 0.017
AS at 5 min＜7 0.77 0.28-2.05 0.610
RDS 2.46 0.50-18.71 0.283
CLD 1.60 0.29-8.49 0.579
PDA 1.05 0.37-2.95 0.926
NEC 8.97e-8 0-18.84 0.436
Sepsis 2.03 0.17-49.81 0.585
Severe IVH 2.68 0.14-87.31 0.518
ROP 2.17 0.74-6.48 0.156
PVL＊ 6.90 1.35-38.25 0.021
ACS,  antenatal corticosteroid use; AOR,  adjusted odds ratio; AS,  
Apgar score; CI,  conﬁdence interval; CLD,  chronic lung disease;  
IVH,  intraventricular hemorrhage; NDI,  neurodevelopmental impair-
ment; NEC,  necrotizing enterocolitis; NDI,  neurodevelopmental 
impairment; PDA,  patent ductus arteriosus; PIH,  pregnancy-in-
duced hypertension; ROP,  retinopathy of prematurity; PVL,  
periventricular leukomalacia; RDS,  respiratory distress syndrome.  
＊indicates p-value＜0.05.
Table 7　 Risk factor analysis for DQ by KSPD test with least 
squares method
Risk factors t-value 95%CI P-value
Primiparity －0.44 －4.43-2.83 0.662
PIH －0.51 －5.52-3.27 0.612
Chorioamnionitis 　0.55 －3.78-6.70 0.581
ACS 　1.15 －1.64-6.10 0.254
Male －0.38 －4.21-2.87 0.706
Gestational age (weeks)＊ 　2.45 　0.44-4.29 0.017
AS at 5 min＜7 －0.91 －6.03-2.26 0.368
RDS 　0.21 －4.19-5.17 0.836
CLD －1.29 －12.47-2.68 0.202
PDA 　0.79 －2.56-5.95 0.430
NEC －0.17 －17.60-14.76 0.862
Sepsis －0.07 －9.84-9.19 0.946
Severe IVH＊ －2.36 －35.44-－3.01 0.021
ROP＊ －2.40 －10.04-－0.93 0.019
PVL＊ －2.52 －16.09-－1.89 0.014
ACS,  antenatal corticosteroid use; AS,  Apgar score; CI,  conﬁ-
dence interval; CLD,  chronic lung disease; DQ,  developmental 
quotient; IVH,  intraventricular hemorrhage; KSPD,  Kyoto Scale of 
Psychological Development; NDI,  neurodevelopmental impairment;  
NEC,  necrotizing enterocolitis; NDI,  neurodevelopmental impair-
ment; PDA,  patent ductus arteriosus; PIH,  pregnancy-induced 
hypertension; ROP,  retinopathy of prematurity; PVL,  periventricu-
lar leukomalacia; RDS,  respiratory distress syndrome.  ＊indicates 
p-value＜0.05.
Table 8　 Evaluated cases vs. those that were LTF and transferred after discharge
Characteristic Evaluated (n＝157) LTF,  transfer AD (n＝41) MD or RR (95%CI) P
Maternal age (years) Mean (SD) 31.7 (5.6) 31.5 (6.0) 0.2 (－1.7-2.2) 0.822
Primiparity n (%) 84 (53.5) 19 (46.3) 1.2 (0.8-1.7) 0.414
Diabetes n (%) 5 (3.2) 0 (0) － 0.586
PIH n (%) 41 (26.1) 11 (26.8) 0.97 (0.55-1.7) 0.926
Chorioamnionitis n (%) 18 (11.5) 2 (4.9) 2.4 (0.57-9.7) 0.260
PROM n (%) 52 (33.1) 11 (26.8) 1.2 (0.71-2.1) 0.441
ACS n (%) 96 (61.2) 29 (70.7) 0.86 (0.68-1.1) 0.257
Cesarean section n (%) 142 (90.5) 38 (92.7) 0.98 (0.88-1.1) 1.000
Male n (%) 80 (51.0) 17 (41.5) 1.2 (0.83-1.8) 0.279
Gestational age (weeks)＊ Mean (SD) 29.2 (2.7) 30.3 (2.7) －1.1 (－2.0-－0.18) 0.020
Birth weight (g)＊ Mean (SD) 1,043 (279) 1,165 (212) －122 (－214-－30) 0.010
SGA n (%) 63 (40.1) 18 (43.9) 0.91 (0.62-1.4) 0.662
AS at 1 min＜7＊ n (%) 92 (58.6) 16 (39.0) 1.5 (1.0-2.3) 0.025
AS at 5 min＜7 n (%) 43 (27.6) 8 (19.5) 1.4 (0.72-2.8) 0.295
RDS n (%) 120 (76.4) 32 (78.1) 0.98 (0.81-1.2) 0.827
CLD n (%) 11 (7.0) 2 (4.9) 1.4 (0.33-6.2) 1.000
PDA n (%) 61 (38.9) 15 (36.6) 1.1 (0.68-1.7) 0.790
NEC n (%) 1 (0.6) 0 (0) － 1.000
Sepsis n (%) 4 (2.6) 2 (4.9) 0.52 (0.10-2.8) 0.606
Severe IVH n (%) 3 (1.9) 0 (0) － 1.000
ROP＊ n (%) 36 (22.9) 3 (7.3) 3.1 (1.0-9.7) 0.027
PVL n (%) 11 (7.0) 1 (2.4) 2.9 (0.38-21.6) 0.466
ACS,  antenatal corticosteroid use; AD,  after discharge; AS,  Apgar score; CI,  conﬁdence interval; CLD,  chronic lung disease; IVH,  
intraventricular hemorrhage; LTF,  lost to follow-up; MD,  mean diﬀerence; NEC,  necrotizing enterocolitis; NDI,  neurodevelopmental 
impairment; PDA,  patent ductus arteriosus; PIH,  pregnancy-induced hypertension; ROP,  retinopathy of prematurity; PROM,  premature 
rupture of the membranes; PVL,  periventricular leukomalacia; RDS,  respiratory distress syndrome; RR,  risk ratio; SGA,  small for gesta-
tional age.  ＊indicates p-value＜0.05.
Discussion
　 In the present study we examined VLBWIs born in 
2005-2012 according to their BW.  Kono et al.  has 
reported the detailed from their database analysis of 
Japanese infants born in 2003-2004 [4].  Speciﬁcally,  
they found that the percentages of infants weighing 
500 g,  501-750 g,  751-1,000 g,  1,001-1,250 g,  and 
1,251-1,500 g were 3.9 ,  18.2 ,  22.1 ,  25. 6 ,  
and 30.1 ,  respectively.  At our hospital,  infants 
weighing 500 g comprised 0.9  of the total VLBWI 
population.  As such,  our VLBWIs would weigh more 
than those in the study by Kono et al.  [4].  Our com-
parison of our results to those of Kono et al.  revealed 
that rates of death or NDI among our infants were 
higher,  particularly in the 751-1,000 g BW group.  
Kusuda et al.  showed recent improvements of neonatal 
care during 2003-2008 [6].  Even though the infants 
in our present analysis were heavier and the study 
period was later,  the neonatal outcomes in the present 
study appear to be worse.  During the study period,  
there were 6 or 7 pediatricians and a few residents 
taking care of the patients in the pediatric ward and 
NICU.  Two neonatologists who were among the seven 
pediatricians were not always available to handle the 
problems of preterm infants.  This shortage of staﬀ 
could be one of the reasons why the neonatal outcomes 
of our hospitalʼs VLBWI cases were worse.
　 In our analysis,  the main causes of death before 
discharge included IVH,  sepsis,  and PPHN (Table 4).  
Previous studies have reported these diseases as risk 
factors for mortality and morbidity [1,5,18].  We 
observed herein that the risk factors for long-term 
outcomes were early GA and PVL (Table 6),  both of 
which have already been reported as risk factors 
[1,5,19].  Our analysis of the DQ scores obtained by 
the KSPD test with least-squares method showed that 
ROP was also a risk factor.  Our study ﬁndings sug-
gest that early GA,  IVH,  sepsis,  PPHN,  ROP,  and 
PVL in particular should be monitored closely.
　 Neonatal treatment strategies must be reevaluated 
so that the incidence of these diseases can be greatly 
decreased.  In terms of sepsis,  infection control is 
extremely important.  Our recent infection control 
eﬀorts include motivating the medical staﬀ not to 
spread infections such as methicillin-resistant staphy-
lococcus aureus (MRSA),  and reevaluating the proce-
dure used for percutaneously inserted central cathe-
ters,  because careful fundamental techniques would be 
the ﬁrst step to decrease the incidence of sepsis.  As 
for IVH,  PPHN,  ROP and PVL,  early stabilization 
and maintaining good cardiopulmonary status are 
essential.  We also organized a symposium for improv-
ing the respiratory management of extremely low birth 
weight infants with other adjacent NICUs [20].  Our 
hospitalʼs weakness in the area of respiratory manage-
ment was correctly pointed out at the symposium,  
which led to direct clinical improvement.  In the near 
future we hope to organize another symposium to 
address circulation.
　 In the present study and the study of Kono et al.,  
the percentages of infants who were transferred or 
LTF were 20.7  and 32.9  (p＝0.0001),  respec-
tively [4].  Notably,  our study had fewer infants who 
were both transferred and LTF.  The characteristics 
of these infants included late GA,  high BW,  high AS 
at 1 min,  and less ROP (Table 8),  indicating a lower 
rate of NDI.  For both our study and that by Kono et 
al.,  the possibility remains that the rates of death or 
NDI were overestimated [4].
　 The present study has several limitations.  First,  
our study population was somewhat small,  and we plan 
to continue these analyses further cases are accumu-
lated.  Second,  the percentage of infants who were 
transferred or LTF was fairly high,  indicating the 
need for a closer follow-up of VLBWIs in the future.
　 In conclusion,  our neonatal outcomes seem to be 
worse than those reported in the NRNJ database.  The 
main causes of death before discharge were IVH,  sep-
sis,  and PPHN,  whereas the risk factors for death 
after discharge or NDI were early GA and PVL.  
Given these ﬁndings,  improved strategies for treating 
VLBWIs continue to be necessary.
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